Table 3.
Reference, Year, Publication Type | TXA Group (total sample size) | Procedure | Concentration of TXA, Volume, Mode of Administration | Comparator | Bleeding * | Postoperative Hemorrhagic Incidence/Intervention/Transfusion † |
---|---|---|---|---|---|---|
Sabry 2018, article64 | 35 (70) | Lung decortication | 30 mg/ml, 100 ml, poured into pleural cavity, drains clamped for 30–45 minutes | 100 ml saline as placebo | Postoperative blood loss drain production at 48 h (ml); TXA = 383 ± 120 vs placebo = 633 ± 164 | Transfusion need (units of transfused blood) mean ± SD: TXA = 0.7 ± 0.9 vs placebo = 1.5 ± 1.1 |
Sallam 2019, article65 | 43 (86) | Open hysterectomy | 20 mg/ml, 50 ml irrigation, 50 ml intraabdominally | 50 + 50 ml saline as placebo | Total blood loss (ml) TXA 395 ± 118 vs placebo 609 ± 119, p < 0.001 |
Transfusion need (n): TXA = 2 vs placebo = 4 |
Shady 2018, article66 | 35 (70) | Open myomectomy | 20 mg/ml, 100 ml, soaked gauze for 5 minutes | 100 ml saline as placebo | Total blood loss (ml) TXA = 684 ± 215 vs placebo = 1080 ± 126, p < 0.001 | Transfusion need (n): TXA = 7 vs placebo = 19 |
Pourfakhr 2016, article63 | 186 total | Prostatectomy | 100 mg/ml, 5ml, topical irrigation after resection | 5 ml saline as placebo | Total blood loss (ml) TXA = 340 ± 152 vs placebo 515 ± SD not given, p = 0.01 | Transfusion need (n): TXA = 0 vs placebo = 5 |
TXA, tranexamic acid; SD, standard deviation.
Values are mean unless otherwise stated.
Values (n) are number of patients unless otherwise stated.